ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q4 2024 Earnings Call Transcript
Operator: Good morning, everyone. Welcome to today's ANI Pharmaceuticals Fourth Quarter 2024 Earnings Results Call. Please note, this call is being recorded.
Ani Pharmaceuticals Inc (ANIP)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 1,002,849 | $55,437,493 | +90% | 0.02% |
| 2. | Deep Track Capital David Kroin | 649,042 | $35,879,042 | +29% | 1.33% |
| 3. | Citadel Investment Group Ken Griffin | 591,594 | $32,703,317 | +12% | 0% |
| 4. | Ranger Investment Management Conrad Doenges (Cio) | 577,738 | $31,937,357 | 2.01% | |
| 5. | Tang Capital Management Kevin C. Tang | 317,500 | $17,551,400 | -30% | 1.16% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $27.69 | 7,224 | 169,650 | 2022-03-21 | Filing | ||
| $27.76 | 5,000 | 53,388 | 2022-03-21 | Filing | ||
| $27.87 | 5,000 | 393,226 | 2022-03-21 | Filing | ||
| $27.15 | 5,000 | 388,226 | 2022-03-18 | Filing | ||
| $27.65 | 5,000 | 5,000 | 2022-03-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $60.86 | 1,000 | Officer | 66,525 | 2025-03-07 | Filing | |
| $60.00 | 5,084 | Officer | 94,092 | 2025-03-05 | Filing | |
| $60.03 | 300 | Officer | 99,176 | 2025-03-05 | Filing | |
| $60.20 | 1,000 | Officer | 68,624 | 2025-02-21 | Filing | |
| $59.54 | 400 | Officer | 83,478 | 2025-02-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,738,572 | $151,388,261 | 0% | |
| 2. | 1,314,372 | $72,658,484 | 0% | |
| 3. | 737,288 | $40,757,281 | 0% | |
| 4. | 699,618 | $38,674,883 | 0% | |
| 5. | 685,730 | $37,905,950 | 0% |
News See All
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q3 2024 Earnings Call Transcript
Operator: Good day, everyone, and welcome to today's ANI Pharmaceuticals Inc Third Quarter 2024 Earnings Results Call. Please note that this call is being recorded.
10 Cheap Pharmaceutical Stocks to Buy According to Short Sellers
The pharmaceutical industry is one of the most interesting sectors to invest in.
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q2 2024 Earnings Call Transcript
Operator: Good day, everyone, and welcome to today's ANI Pharmaceuticals, Inc. Second Quarter 2024 Earnings Results Call. [Operator Instructions].
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q1 2024 Earnings Call Transcript
ANI Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.937 EPS, expectations were $0.98.
11 Best Small Cap Pharma Stocks to Invest In
In this piece, we will take a look at the 11 best small cap pharma stocks to invest in.
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q4 2023 Earnings Call Transcript
ANI Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $1, expectations were $0.8. ANI Pharmaceuticals, Inc.
13 Stocks That Will Double in 2024
Last year turned out to be wondrous for the US stock market as the S&P 500 gained over 25% compared to its 18% decline in the previous year.
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q3 2023 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the ANI Pharmaceuticals, Inc. Third Quarter 2023 Earnings Results Call. At this time, all participants are in a listen-only mode.
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q2 2023 Earnings Call Transcript
Operator: Good morning, everyone. My name is Chelsea and I will be your conference operator.
Billionaire Hedge Funds
